Relmada Therapeutics
RLMD
RLMD
80 hedge funds and large institutions have $298M invested in Relmada Therapeutics in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+8
Holders Change %
+11.11%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
13
Increased
26
Reduced
24
Closed
5
Calls
$6.72M
Puts
$17K
Net Calls
+$6.71M
Net Calls Change
+$925K
Top Buyers
| 1 |
1
BlackRock
New York
|
$47.9M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$9.14M |
| 3 |
3
Alkeon Capital Management
New York
|
$1.6M |
| 4 |
ACA
4
Avoro Capital Advisors
New York
|
$48.9M |
| 5 |
5
Millennium Management
New York
|
$800K |
